| Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis (NCT02335099) | University of Virginia | 2014-12-01 |
| Autologous Platelet-Rich Plasma Cream for Photoaging and Chronological Skin Aging (NCT02303496) | Acibadem University | 2014-12-01 |
| Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma (NCT02200562) | University of Utah | 2014-12-01 |
| Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA) (NCT02919371) | King Faisal Specialist Hospital & Research Center | 2014-12-01 |
| SAD/MAD Study of a New Formulation of Nebulised RPL554 in Healthy Subjects and COPD Subjects (NCT02307162) | Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA | 2014-12-01 |
| Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery (NCT02314286) | Soroka University Medical Center | 2014-12-01 |
| Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults (NCT02296541) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-12-01 |
| Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect (NCT02291926) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2014-12-01 |
| Adalimumab PK Bioequivalence Study to EU and US Sourced Humira (NCT02472912) | Mylan Inc. | 2014-12-01 |
| Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury (NCT01731444) | University of Manitoba | 2014-12-01 |
| Safety Study of Using Regulatory T Cells Induce Liver Transplantation Tolerance (NCT01624077) | Nanjing Medical University | 2014-12-01 |
| APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery (NCT02166255) | Wake Forest University Health Sciences | 2014-12-01 |
| Mesenchymal Stem Cell and Islet Co-transplantation (NCT02384018) | Medical University of South Carolina | 2014-12-01 |
| A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid Tumors (NCT02317419) | Hoffmann-La Roche | 2014-12-01 |
| Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults (NCT02272049) | Children's Hospital Medical Center, Cincinnati | 2014-12-01 |
| Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly and and Healthy Younger Adult Participants (NCT02345148) | Janssen Research & Development, LLC | 2014-12-01 |
| A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease (NCT02323334) | Eli Lilly and Company | 2014-12-01 |
| A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors (NCT02354547) | SynerGene Therapeutics, Inc. | 2014-12-01 |
| A Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy Subjects (NCT02316756) | Pfizer | 2014-12-01 |
| Ganetespib Window of Opportunity Study in Head and Neck Cancers (NCT02334319) | Emory University | 2014-12-01 |
| Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma (NCT01531244) | Washington University School of Medicine | 2014-12-01 |
| Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies (NCT02315118) | National University Hospital, Singapore | 2014-12-01 |
| Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis (NCT02442960) | Stanford University | 2014-12-01 |
| Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548 (NCT02327546) | Akebia Therapeutics | 2014-12-01 |
| A Phase 1 Study of AMG 211 in Participants With Advanced Gastrointestinal Cancer (NCT02291614) | Amgen | 2014-11-27 |
| A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) (NCT02327078) | Incyte Corporation | 2014-11-26 |
| Crossover, Single Dose Randomized, Bioequivalence of Ketoprofen Lysine Salt Immediate Release vs Oral Solution (NCT02350296) | Dompé Farmaceutici S.p.A | 2014-11-26 |
| A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001) (NCT02269735) | Merck Sharp & Dohme LLC | 2014-11-26 |
| Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors (NCT02301130) | Kyowa Kirin, Inc. | 2014-11-26 |
| Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) (NCT02319369) | Daiichi Sankyo | 2014-11-25 |
| Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 (NCT02311621) | Seattle Children's Hospital | 2014-11-25 |
| A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) (NCT02293980) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-11-25 |
| Effect of Food on the Pharmacokinetics of NNC0123-0000-0338 in a Tablet Formulation in Healthy Subjects (NCT02304627) | Novo Nordisk A/S | 2014-11-24 |
| Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver (NCT02273362) | National Cancer Institute (NCI) | 2014-11-24 |
| Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants (NCT05995691) | Amgen | 2014-11-24 |
| Use of PET/MR Imaging in Chronic Pain (NCT03195270) | Stanford University | 2014-11-24 |
| A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB (NCT02375698) | Aeras | 2014-11-21 |
| Effect of Food on Opicapone (NCT03116308) | Bial - Portela C S.A. | 2014-11-21 |
| AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer (NCT02298946) | National Cancer Institute (NCI) | 2014-11-21 |
| Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones (NCT02230514) | Banc de Sang i Teixits | 2014-11-20 |
| MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation (NCT02250300) | Mehdi Hamadani | 2014-11-19 |
| Trial of AEB071 in Combination With BYL719 in Patients With Melanoma (NCT02273219) | Columbia University | 2014-11-19 |
| Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma (NCT02209376) | University of Pennsylvania | 2014-11-18 |
| Neural Basis of Decision-Making Deficits in Traumatic Brain Injury (NCT02169310) | National Institute of Neurological Disorders and Stroke (NINDS) | 2014-11-18 |
| A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects (NCT02289495) | GlaxoSmithKline | 2014-11-18 |
| Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole (NCT02234570) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-11-17 |
| Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264 (NCT02424799) | GlaxoSmithKline | 2014-11-17 |
| TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery (NCT02180698) | Fred Hutchinson Cancer Center | 2014-11-17 |
| Study to Evaluate Safety and Efficacy in Adult Subjects With ITP (NCT02273960) | Bristol-Myers Squibb | 2014-11-17 |
| Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers (NCT02293148) | GlaxoSmithKline | 2014-11-17 |
| A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects (NCT02289482) | GlaxoSmithKline | 2014-11-17 |
| Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer (NCT02101580) | Polaris Group | 2014-11-17 |
| Insulin Resistance and Reward Signaling in Obesity (NCT02241603) | VA Office of Research and Development | 2014-11-17 |
| Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement: Feasibility (NCT03507075) | Mikhail Koffarnus | 2014-11-15 |
| Continuous Multiple Dose PB-119 Injection in Health Volunteers (NCT03062774) | PegBio Co., Ltd. | 2014-11-15 |
| BMS-986012 in Relapsed/Refractory SCLC (NCT02247349) | Bristol-Myers Squibb | 2014-11-14 |
| sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS (NCT02239562) | Christopher O'Brien, MD | 2014-11-14 |
| Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer (NCT02163733) | AstraZeneca | 2014-11-14 |
| 3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Adolescents (NCT02280447) | Statens Serum Institut | 2014-11-13 |
| Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer (NCT02215096) | GlaxoSmithKline | 2014-11-13 |
| Anti-OX40 Antibody in Head and Neck Cancer Patients (NCT02274155) | Providence Health & Services | 2014-11-12 |
| A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC) (NCT02240433) | Eli Lilly and Company | 2014-11-12 |
| Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB (NCT01751568) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-11-12 |
| Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers (NCT02293161) | GlaxoSmithKline | 2014-11-11 |
| BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC) (NCT02204072) | Boehringer Ingelheim | 2014-11-11 |
| mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian (NCT02208375) | M.D. Anderson Cancer Center | 2014-11-11 |
| Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma (NCT02243436) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2014-11-11 |
| LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma (NCT02138929) | M.D. Anderson Cancer Center | 2014-11-10 |
| A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer (NCT02415023) | Hutchison Medipharma Limited | 2014-11-09 |
| Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva) (NCT02157883) | AstraZeneca | 2014-11-06 |
| A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT02308761) | Hoffmann-La Roche | 2014-11-06 |
| Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects (NCT02281370) | GlaxoSmithKline | 2014-11-05 |
| Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies (NCT02129582) | Case Comprehensive Cancer Center | 2014-11-05 |
| Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer (NCT02228369) | AstraZeneca | 2014-11-05 |
| Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets (NCT02078284) | U.S. Army Medical Research and Development Command | 2014-11-05 |
| Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study (NCT02303431) | Daiichi Sankyo | 2014-11-05 |
| Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma (NCT02244489) | Sierra Oncology LLC - a GSK company | 2014-11-05 |
| A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI) (NCT02277600) | ViiV Healthcare | 2014-11-05 |
| Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHL (NCT02151903) | Alopexx Oncology, LLC | 2014-11-04 |
| Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab) (NCT02286219) | Bristol-Myers Squibb | 2014-11-04 |
| A Study of High Dose MHAA4549A in Healthy Volunteers (NCT02284607) | Genentech, Inc. | 2014-11-03 |
| A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants (NCT05976360) | Sanofi | 2014-11-02 |
| Comparative Oral Bioavailability Study of MT-1303 (NCT02310048) | Tanabe Pharma Corporation | 2014-11-01 |
| In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer (NCT01923233) | Mirror Biologics, Inc. | 2014-11-01 |
| Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood (NCT02306629) | UCB Biopharma S.P.R.L. | 2014-11-01 |
| Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. (NCT02300818) | American Society Of Thermalism And Climatology Inc | 2014-11-01 |
| Bioequivalence Study With Pharmacokinetic Endpoints, Comparing a Single Dose of Iron Sucrose Azad Injection of Azad Pharma Corporation (AG), With a Single Dose of Venofer® Injection of Vifor Corporation (AG) in Healthy Adult Volunteers (NCT02391181) | Azad Pharma AG | 2014-11-01 |
| Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO (NCT02006147) | Taiwan Liposome Company | 2014-11-01 |
| Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke (NCT02605707) | Southern Medical University, China | 2014-11-01 |
| Single-Dose Study of MT203 (NCT02354599) | Takeda | 2014-11-01 |
| CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers (NCT02288338) | Chong Kun Dang Pharmaceutical | 2014-11-01 |
| Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors (NCT02307240) | Curis, Inc. | 2014-11-01 |
| Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma (NCT02304289) | University Hospital, Ghent | 2014-11-01 |
| A Study of LY2623091 in Healthy Participants (NCT02300259) | Eli Lilly and Company | 2014-11-01 |
| Comparative Bioavailability Study of Two Misoprostol Formulations (NCT02516631) | Region Skane | 2014-11-01 |
| Carfilzomib for the Prevention of Graft Versus Host Disease (NCT01991301) | Sheba Medical Center | 2014-11-01 |
| Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients (NCT02099591) | Kyowa Kirin Pharmaceutical Development Ltd | 2014-11-01 |
| RDEA3170 and Allopurinol Combination Study in Gout Subjects (NCT02279641) | Ardea Biosciences, Inc. | 2014-11-01 |
| Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer (NCT02303912) | Imperial College Healthcare NHS Trust | 2014-11-01 |
| Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin (NCT02267408) | McMaster University | 2014-11-01 |